Rapidly progressive diffuse large B-cell lymphoma with initial clinical presentation mimicking seronegative Wegener's granulomatosis

Keyphrases

• Aggressive B-cell Lymphoma 33%
• Autoimmune Disease 33%
• Bone Marrow 33%
• Chemoresistance 33%
• Chemoresistant 33%
• Chemotherapy 33%
• Clinical Clearance 33%
• Clinical Improvement 33%
• Clinical Presentation 100%
• Clonality 33%
• Cyclophosphamide 33%
• Diffuse Large B-cell Lymphoma (DLBCL) 100%
• Extranodal 33%
• Generalized Lymphadenopathy 33%
• Granulomatous Vasculitis 33%
• Immunosuppressive Agents 33%
• Inflammatory Infiltrate 33%
• Intensive Chemotherapy 33%
• Large B-cell Lymphoma 33%
• Lung 33%
• Lung Lesions 33%
• Lymphoma 100%
• Lymphoproliferative Disorders 33%
• Male Patients 33%
• Non-cancer 33%
• Oral Methotrexate 33%
• Polyarthritis 33%
• Prednisone 33%
• Rapidly Progressive 100%
• Skin Lesions 33%
• Suboptimal Dose 33%
• Wegener's Granulomatosis 100%
• Young Males 33%

Medicine and Dentistry

• Autoimmune Disease 50%
• B-Cell Lymphoma 50%
• Biopsy 50%
• Clonal Variation 50%
• Cyclophosphamide 50%
• Diffuse Large B-Cell Lymphoma 100%
• Disease 100%
• Drug Resistance 50%
• Granulomatosis with Polyangiitis 100%
• Granulomatous Vasculitis 50%
• Histopathology 50%
• Immunosuppressive Drug 50%
• Inflammatory Infiltrate 50%
• Large-Cell Lymphoma 50%
• Lung Lesion 50%
• Lymphoproliferative Disease 50%
• Masking 50%
• Methotrexate 50%
• Persistent Generalized Lymphadenopathy 50%
• Polyarthritis 50%
• Prednisone 50%
• Skin Defect 50%